Koers Silk Road Medical, Inc
Aandelen
SILK
US82710M1009
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
17,65 USD | +0,46% | +1,32% | +43,85% |
Omzet 2024 * | 196 mln. 182 mln. | Omzet 2025 * | 217 mln. 202 mln. | Marktkapitalisatie | 691 mln. 644 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -54 mln. -50,3 mln. | Nettowinst (verlies) 2025 * | -50 mln. -46,57 mln. | EV/omzet 2024 * | 3,49 x |
Nettoliquiditeiten 2024 * | 9,23 mln. 8,6 mln. | Nettoliquiditeiten 2025 * | 38,77 mln. 36,11 mln. | EV/omzet 2025 * | 3,01 x |
K/w-verhouding 2024 * |
-12,9
x | K/w-verhouding 2025 * |
-13,9
x | Werknemers | 474 |
Dividendrendement 2024 * |
0,73% | Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,07% |
Recentste transcriptie over Silk Road Medical, Inc
1 dag | +0,46% | ||
1 week | +1,32% | ||
Lopende maand | -3,66% | ||
1 maand | -4,23% | ||
3 maanden | +16,04% | ||
6 maanden | +180,60% | ||
Lopend jaar | +43,85% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Charles McKhann
CEO | Chief Executive Officer | 55 | 02/11 |
Lucas Buchanan
DFI | Director of Finance/CFO | 46 | 01-08-09 |
William Whealon
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Don Zurbay
BRD | Director/Board Member | 56 | 26-03-18 |
Kevin Ballinger
BRD | Director/Board Member | 51 | 03-12-20 |
Jack Lasersohn
CHM | Chairman | 70 | 01-04-07 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.06% | 509 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 17,65 | +0,46% | 621 585 |
24-04-24 | 17,57 | -0,57% | 607 675 |
23-04-24 | 17,67 | +1,49% | 599 210 |
22-04-24 | 17,41 | +0,52% | 946 264 |
19-04-24 | 17,32 | -0,57% | 373 078 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,85% | 691 mln. | |
-2,92% | 185 mld. | |
-3,80% | 105 mld. | |
-5,48% | 66,59 mld. | |
+11,22% | 54,66 mld. | |
+16,74% | 47,78 mld. | |
+4,06% | 41,26 mld. | |
+4,56% | 26,95 mld. | |
+1,64% | 26,37 mld. | |
+12,96% | 24,8 mld. |